A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma (SKOPOS)

Clinical Trial ID NCT01569919

PubWeight™ 4.91‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01569919

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials. Cancer Manag Res 2015 1.19
2 Trial watch: Peptide vaccines in cancer therapy. Oncoimmunology 2012 1.17
3 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
4 New roads open up for implementing immunotherapy in mesothelioma. Clin Dev Immunol 2012 0.80
5 Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4. Front Oncol 2013 0.78
Next 100